ERBB2 and breast cancer: We have previously shown that palbociclib is efficacious in the mouse mammary tumor virus (MMTV) - Neu GEMM (Her2/Neu) model, a model that is similar to human HER2-positive (HER2+) luminal breast cancer [29].